Search

everythinglearnresearchcommunity

for

Search:↓

Machine learning optimized microneedles promote hair regrowth better than minoxidil without safety risks.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

JAK inhibitors may help improve symptoms in adults with APECED.

These new skin treatments are safer and more effective with minimal side effects.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Low-level laser therapy reduces orthodontic relapse in rats, but fulvic acids do not.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Adding a second method to PROTACs could improve cancer treatment.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

Majocchi's granuloma can occur in kidney transplant patients on tacrolimus and can be treated with antifungal medication.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

JAK inhibitors show promise in treating moderate to severe alopecia areata.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

Injectable biostimulators can improve skin by boosting collagen and fat cell activity, but more research is needed to confirm their safety and effectiveness.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Laminin-511 may contribute to psoriasis by affecting skin cell growth and survival.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Mrp3 may aid in wound healing and hair growth.

Natural plant products like Proanthocyanidins and curcumin may help treat ischemic stroke by reducing inflammation.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.